Alpha Teknova | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 10.45 M

LB filings

2025.11.07 21:14

I'm PortAI, I can summarize articles.

Revenue: As of FY2025 Q3, the actual value is USD 10.45 M, beating the estimate of USD 10.23 M.

EPS: As of FY2025 Q3, the actual value is USD -0.08, beating the estimate of USD -0.094.

EBIT: As of FY2025 Q3, the actual value is USD -3.827 M.

Lab Essentials: Revenue for the three months ended September 30, 2025, was $8.3 million, an increase of $1.1 million or 16.0% compared to $7.2 million for the same period in 2024.
Clinical Solutions: Revenue for the three months ended September 30, 2025, was $1.7 million, a decrease of $0.3 million or 13.1% compared to $2.0 million for the same period in 2024.
Other: Revenue for the three months ended September 30, 2025, was $0.4 million, a decrease of $0.01 million or 2.4% compared to $0.45 million for the same period in 2024.

Net Loss: For the three months ended September 30, 2025, net loss was $4.3 million, compared to $7.6 million for the same period in 2024.
Gross Profit: Gross profit for the three months ended September 30, 2025, was $3.2 million, compared to $0.09 million for the same period in 2024, with a gross profit percentage of 30.7% compared to 0.9% in 2024.
Operating Loss: Operating loss for the three months ended September 30, 2025, was $4.0 million, compared to $7.4 million for the same period in 2024.

Net Cash Used in Operating Activities: For the nine months ended September 30, 2025, net cash used in operating activities was $8.2 million, compared to $11.5 million for the same period in 2024.
Net Cash Provided by Investing Activities: For the nine months ended September 30, 2025, net cash provided by investing activities was $7.5 million, compared to net cash used of $25.9 million for the same period in 2024.
Net Cash Provided by Financing Activities: For the nine months ended September 30, 2025, net cash provided by financing activities was $0.2 million, compared to $15.0 million for the same period in 2024.

Core Business Focus: The company plans to invest in processes and infrastructure to improve operating efficiency and expand capacity at its facilities, including the ramp-up of new manufacturing, warehouse, and distribution facilities.
Non-Core Business: The company is monitoring economic uncertainty and inflation, which may impact customer demand and costs.
Priority: The company aims to meet minimum net revenue requirements of $39.0 million for the twelve months ending December 31, 2025, and maintain a minimum cash requirement of $8.0 million.